Polygon Management »

Silence Therapeutics shares owned by Polygon Management

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Polygon Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2M 365k 6.08

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Lyft Cl A Com (LYFT)
Autolus Therapeutics Spon Ads (AUTL)
Sprinklr Cl A (CXM)
Workiva Com Cl A (WK)
Annexon (ANNX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Arrowhead Pharmaceuticals (ARWR)
Pharvaris N V (PHVS)
Axsome Therapeutics (AXSM)
Dyne Therapeutics (DYN)
Mbx Biosciences (MBX)
Rapt Therapeutics Com New (RAPT)

View all positions for Polygon Management

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Nantahala Capital Management
Vivo Capital
Nextech Invest
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
5AM Venture Management
Polygon Management
Millennium Management
SG Americas Securities
Boothbay Fund Management
UBS Group

View all funds holding Silence Therapeutics